NK2R | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

95 results for “NK2R”

Trials

View all 70 →

An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

27 participants · First posted Oct 21, 2011

Etirinotecan Pegol (NKTR-102) in NSCLC

40 participants · First posted Jan 23, 2013

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors

28 participants · First posted Aug 16, 2016

Drugs

View all 19 →

NKTR-034

NKTR-228

NKTR-194

News

NK2R Agonist Shows Promise for Weight Loss Without Muscle Loss in Preclinical Study

Outlook Therapeutics Faces Setback in AMD Trial; Other R&D Updates

NKTR-255 Shows Promise in Reversing Radiation-Induced Lymphopenia in NSCLC

Page 1 of 10